ALAM
BIO icon

Asahi Life Asset Management’s Bio-Rad Laboratories Class A BIO Stock Holding History

Asahi Life Asset Management’s Portfolio BIO Stock Details BIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-1,065
Closed -$350K – 163
2024
Q4 		$350K Buy
+1,065
New +$361K 0.21% 111
2020
Q4 		– Sell
-400
Closed -$206K – 196
2020
Q3 		$206K Buy
+400
New +$203K 0.03% 177

Other funds holding BIO

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
First Eagle Investment Management
First Eagle Investment Management New York $60.8B AUM 26.63% 1-Year Est. Return
Veritas Asset Management
Veritas Asset Management London, United Kingdom $5.56B AUM 3.46% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Ariel Investments
Ariel Investments Chicago, Illinois $10B AUM 42.59% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
EARNEST Partners
EARNEST Partners Atlanta, Georgia $27.7B AUM 52.44% 1-Year Est. Return
VanEck Associates
VanEck Associates New York $164B AUM 112.45% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Asahi Life Asset Management's BIO Position: Q1 2025 in Review

Asahi Life Asset Management sold out of Bio-Rad Laboratories Class A (BIO) in Q1 2025, closing a stake of 1,065 shares — an estimated $350K sold.

Asahi Life Asset Management first reported a position in BIO in Q3 2020 and held it in 2 quarters. The position peaked at $350K in Q4 2024. 437 funds tracked by Wall St. Rank hold BIO as of Q1 2025.

  • Asahi Life Asset Management reported no remaining Bio-Rad Laboratories Class A position as of Q1 2025 after selling out during the quarter.
  • Asahi Life Asset Management sold 1,065 Bio-Rad Laboratories Class A shares in Q1 2025, an estimated $350K.
  • Asahi Life Asset Management first reported a position in Bio-Rad Laboratories Class A in Q3 2020 and held it in 2 quarters.
  • Asahi Life Asset Management's Bio-Rad Laboratories Class A position peaked at $350K in Q4 2024.
  • 437 funds tracked by Wall St. Rank held Bio-Rad Laboratories Class A as of Q1 2025.

Based on Asahi Life Asset Management's 13F filing for Q1 2025, filed 2 May 2025.